Dissecting Cellulitis of the Scalp: Understanding the Sinus Tracts and How It's Treated

What Is Dissecting Cellulitis of the Scalp?

Dissecting cellulitis of the scalp (DCS) is a rare, chronic inflammatory condition affecting the deep layers of the scalp. The name describes what happens at the microscopic level: the word "dissecting" refers to how the inflammation spreads by creating tunnels (sinus tracts) beneath the scalp skin, cutting through the tissue layer by layer. "Cellulitis" here is somewhat misleading — it is not the kind of cellulitis caused by a straightforward bacterial skin infection. Rather, DCS represents a severe, dysregulated inflammatory response pattern of the scalp.

The alternative name — perifolliculitis capitis abscedens et suffodiens — translates to: inflammation around the hair follicles of the scalp, with abscess formation and interconnecting burrowing tunnels. This name more accurately captures the disease.

DCS is classified as part of the follicular occlusion tetrad, a group of conditions that includes acne conglobata, hidradenitis suppurativa, and pilonidal disease — all of which share a common mechanism of severe follicular inflammation leading to abscess and sinus tract formation.

What Happens Under the Scalp

DCS begins with inflammation around hair follicles deep in the scalp dermis and subcutis (the fat layer beneath the skin). The precise trigger is not fully understood, but bacterial infection, follicular rupture, and possibly an abnormal immune response all contribute:

1. Deep follicular inflammation develops — possibly triggered by follicular obstruction or bacterial colonization
2. Abscesses (pockets of pus) form around follicular structures and extend through the dermis and subcutis
3. Adjacent abscesses connect, forming sinus tracts — interconnected tunnels of purulent material
4. This creates a honeycomb-like network of pus-filled channels beneath the scalp surface
5. The chronic suppuration (pus formation) destroys hair follicles and triggers extensive fibrosis (scarring)
6. Progressive scarring causes permanent, irreversible hair loss in affected areas

Bacterial cultures from DCS drainage typically grow multiple organisms — commonly Staphylococcus aureus, Streptococcus species, and others — but importantly, no single organism is consistently found. This polymicrobial pattern and the poor response to antibiotics alone support the view that DCS is fundamentally inflammatory rather than purely infectious.

Genetic susceptibility appears significant: familial clustering is documented in approximately 30–40% of cases, and the higher prevalence in men of African descent suggests inherited predisposition factors.

Signs and Symptoms

DCS has a distinctive and severe presentation:

• Large, fluctuant (fluid-filled) nodules on the scalp that are often tender and warm to the touch
• Multiple drainage openings — pus drains through several openings simultaneously from connected sinus tracts
• Foul-smelling purulent drainage — often described by patients as the most distressing aspect
• Bridging scars — as healed areas of scarring connect across the scalp, creating a pitted, deformed appearance
• Progressive hair loss — as follicles are destroyed by the ongoing suppuration and scarring
• Pain and tenderness — often significant, limiting activities and sleep
• During severe flares: fever, swollen lymph nodes, and general malaise

Unlike straightforward scalp folliculitis (which involves individual inflamed follicles that resolve with antibiotics), DCS shows interconnected pathways, persistent drainage despite antibiotic therapy, and progressive expansion.

Who Does DCS Affect?

DCS predominantly affects young Black men, with approximately 40% of cases or higher reported in individuals of African descent in dermatology clinic populations. Men significantly outnumber women (approximately 9:1). The condition typically begins in the late teens to early 30s. It can occur in any demographic, but the concentration in this population suggests genetic and possibly androgenic factors.

Treatment Approaches

DCS is one of the most challenging scarring alopecias to treat. Monotherapy — treating with just one type of medication — is usually insufficient. Effective management requires a combination of antimicrobial and anti-inflammatory approaches.

Antibiotic Therapy

Long-term oral antibiotics form the foundation of DCS therapy. Typical options include:

• Tetracyclines (doxycycline 100 mg twice daily) — provide sustained antibacterial coverage with additional anti-inflammatory properties; first-line in many patients
• Trimethoprim-sulfamethoxazole (1 DS tablet twice daily) — an alternative for tetracycline-intolerant patients
• Combination antibiotics — dual therapy (e.g., amoxicillin-clavulanate plus a macrolide) is sometimes used given the polymicrobial nature

Courses typically extend 3–24 months depending on response. Topical antibiotics (mupirocin to affected areas) and antiseptic washes (chlorhexidine) provide adjunctive benefit.

Anti-inflammatory Therapy

Reducing scalp inflammation is often more important than antibiotics for controlling DCS:

• Intralesional corticosteroid injection (triamcinolone 2.5–10 mg/mL) injected directly into draining sinus tracts every 4–6 weeks — suppresses suppuration in 40–50% of patients and can provide meaningful relief from drainage
• Oral corticosteroids (prednisone 0.5–1 mg/kg daily with gradual taper) — effective in about 50–60% of patients, though flares often occur on tapering

Systemic Agents

• Isotretinoin (0.5–1 mg/kg/day) — shows response in 70–80% of select patients in some case series, targeting sebaceous gland activity and follicular inflammation; requires strict monitoring for teratogenicity and laboratory toxicity
• TNF-alpha inhibitors (adalimumab, infliximab) — show promise in refractory cases, with approximately 60–70% of patients demonstrating significant improvement in preliminary reports
• Mycophenolate mofetil, cyclosporine — steroid-sparing immunosuppressants used for severe cases
• Dapsone (50–150 mg daily) — useful as adjunctive therapy in select patients

Surgical Options

For localized disease or specific refractory sinus tracts:

• Incision and drainage of large abscesses provides temporary symptomatic relief
• Excision of sinus tracts and primary closure may help limited areas
• Laser ablation (CO2 laser) of sinus tracts has shown benefit in some cases
• Extensive scalp excision with skin grafting — reserved for severe, refractory cases; carries significant morbidity

Surgical approaches are typically combined with medical therapy rather than used alone. Hair transplantation should be deferred until the disease has been inactive for at least 12–24 months.

Prognosis

DCS is one of the most difficult scarring alopecias to control. With early, aggressive combination medical therapy, approximately 50–60% of patients achieve disease stabilization or improvement. Complete remission is less common; most patients require ongoing therapy. Scarring alopecia that has already occurred is permanent — medical therapy prevents further progression but cannot reverse existing hair loss.

When to See a Dermatologist

• Recurrent painful nodules or abscesses on the scalp that do not respond to antibiotics
• Multiple draining scalp lesions, especially if they seem connected
• Progressive, unexplained hair loss in the context of scalp inflammation
• Odorous discharge from the scalp
• Any suspicion of DCS — early diagnosis and aggressive treatment significantly improves outcomes

Frequently Asked Questions

What causes dissecting cellulitis?

The precise cause is not fully understood. Bacterial infection, follicular rupture, and dysregulated immune responses likely all contribute. Genetic susceptibility is significant, with familial clustering documented in 30–40% of cases. Unlike simple bacterial cellulitis, DCS appears to be a host inflammatory response pattern that involves bacteria as a secondary component rather than a purely infectious disease.

Is dissecting cellulitis contagious?

No. Despite the pus and drainage, DCS is not contagious. Close contacts will not acquire the condition through contact. The underlying pathology is inflammatory rather than infectious in the primary sense.

Will antibiotics alone cure DCS?

Antibiotics alone rarely produce lasting cure. The condition requires combination antimicrobial and anti-inflammatory therapy. Some patients achieve remission with long-term antibiotics combined with anti-inflammatory agents, but many require escalation to systemic agents like isotretinoin or biologics for adequate control.

Can hair grow back after dissecting cellulitis?

Hair follicles destroyed by the suppuration and scarring cannot regenerate — that hair loss is permanent. Early, aggressive treatment is critical precisely because it prevents further follicle destruction. Once the disease is controlled, existing follicles in stable areas are preserved, though new hair cannot grow where scarring has already occurred.

Trusted Resources

• American Academy of Dermatology: Cicatricial Alopecia (Scarring Hair Loss)
• Cicatricial Alopecia Research Foundation

Always consult a board-certified dermatologist for diagnosis and personalized treatment recommendations. This article is for educational purposes only.